What is BRAINWeek?
Developed by the PAINWeek organization—now in its 16th year of exceptional pain management education—BRAINWeek provides live and digital activities addressing the most frequently diagnosed conditions encountered in clinical practice, with an emphasis on collaborative care among specialists and frontline practitioners. The 2022 conference agenda will include courses on the impact of COVID-19, dementia, epilepsy, hearing loss, migraine, multiple sclerosis, sleep, and stroke, as well as special interest sessions on rare CNS disorders such as amyotrophic lateral sclerosis (ALS), CDKL5 Deficiency Disorder, Huntington’s Disease, Rett syndrome.

BRAINWeek Enduring Content

The current estimated annual cost to American society of just nine of the most common neurological diseases is staggering, totaling $789 billion. These conditions include Alzheimer’s disease and other dementias, low back pain, stroke, traumatic brain injury, migraine, epilepsy, multiple sclerosis, spinal cord injury, and Parkinson’s disease.

Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: a summary report and call to action. Ann Neurol. 2017;81:479-484.

Share this event with your community:



Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.